ACE Inhibition and Novel Cardiovascular Risk Factors

NCT00051389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cardiovascular Diseases
Heart Diseases
Hypertension

Interventions

DRUG: Fosinopril

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)